References
- Allen, A. P., Dinan, T. G., Clarke, G., & Cryan, J. F. (2017). A psychology of the human brain-gut-microbiome axis. Social and Personality Psychology Compass, 11(4), e12309. https://doi.org/https://doi.org/10.1111/spc3.12309
- Andrykowski, M. A., Steffens, R. F., Bush, H. M., & Tucker, T. C. (2017). Posttraumatic growth and benefit-finding in lung cancer survivors: The benefit of rural residence? Journal of Health Psychology, 22(7), 896–905. https://doi.org/https://doi.org/10.1177/1359105315617820
- Antoine, P., Dauvier, B., Andreotti, E., & Congard, A. (2018). Individual differences in the effects of a positive psychology intervention: Applied psychology. Personality and Individual Differences, 122, 140–147. https://doi.org/https://doi.org/10.1016/j.paid.2017.10.024
- APA. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association. https://doi.org/https://doi.org/10.1176/appi.books.9780890425596.dsm05
- Barch, D. M., Harms, M. P., Tillman, R., Hawkey, E., & Luby, J. L. (2019). Early childhood depression, emotion regulation, episodic memory, and hippocampal development. Journal of Abnormal Psychology, 128(1), 81–95. https://doi.org/https://doi.org/10.1037/abn0000392
- Beck, A. T., & Bredemeier, K. (2016). A unified model of depression: Integrating clinical, cognitive, biological, and evolutionary perspectives. Clinical Psychological Science, 4(4), 596–619. https://doi.org/https://doi.org/10.1177/2167702616628523
- Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996). Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67(3), 588–597. https://doi.org/https://doi.org/10.1207/s15327752jpa6703_13
- Beleckas, C. M., Guattery, J., Chamberlain, A. M., Khan, T., Kelly, M. P., & Calfee, R. P. (2018). Using patient-reported outcomes measurement information system measures to understand the relationship between improvement in physical function and depressive symptoms. Journal of the American Academy of Orthopaedic Surgeons, 26(24), e511–e518. https://doi.org/https://doi.org/10.5435/JAAOS-D-17-00039
- Belujon, P., & Grace, A. A. (2017). Dopamine system dysregulation in major depressive disorders. The International Journal of Neuropsychopharmacology, 20(12), 1036–1046. https://doi.org/https://doi.org/10.1093/ijnp/pyx056
- Bernaras, E., Jaureguizar, J., & Garaigordobil, M. (2019). Child and adolescent depression: A review of theories, evaluation instruments, prevention programs, and treatments. Frontiers in Psychology, 10, 543–543. https://doi.org/https://doi.org/10.3389/fpsyg.2019.00543
- Bigelow, A. E., Beebe, B., Power, M., Stafford, A.-L., Ewing, J., Egleson, A., & Kaminer, T. (2018). Longitudinal relations among maternal depressive symptoms, maternal mind-mindedness, and infant attachment behavior. Infant Behavior & Development, 51, 33–44. https://doi.org/https://doi.org/10.1016/j.infbeh.2018.02.006
- Boku, S., Nakagawa, S., Toda, H., & Hishimoto, A. (2018). Neural basis of major depressive disorder: Beyond monoamine hypothesis. Psychiatry and Clinical Neurosciences, 72(1), 3–12. https://doi.org/https://doi.org/10.1111/pcn.12604
- Brummelte, S., & Galea, L. A. M. (2016). Postpartum depression: Etiology, treatment and consequences for maternal care. Hormones and Behavior, 77, 153–166. https://doi.org/https://doi.org/10.1016/j.yhbeh.2015.08.008
- Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019). Gut microbial metabolites in depression: Understanding the biochemical mechanisms. Microbial Cell (Graz, Austria), 6(10), 454–481. https://doi.org/https://doi.org/10.15698/mic2019.10.693
- Celano, C. M., Villegas, A. C., Albanese, A. M., Gaggin, H. K., & Huffman, J. C. (2018). Depression and anxiety in heart failure: A review. Harvard Review of Psychiatry, 26(4), 175–184. https://doi.org/https://doi.org/10.1097/HRP.0000000000000162
- Cella, D., Lai, J. S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavazos, J. E., Reder, A. T., Sufit, R., Simuni, T., Holmes, G. L., Siderowf, A., Wojna, V., Bode, R., McKinney, N., Podrabsky, T., … Moy, C. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology, 78(23), 1860–1867. https://doi.org/https://doi.org/10.1212/WNL.0b013e318258f744
- Cepeda, M. S., Katz, E. G., & Blacketer, C. (2017). Microbiome-gut-brain axis: Probiotics and their association with depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 29(1), 39–44. https://doi.org/https://doi.org/10.1176/appi.neuropsych.15120410
- Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019). Butyrate suppresses demyelination and enhances remyelination. Journal of Neuroinflammation, 16(1), 113–165. https://doi.org/https://doi.org/10.1186/s12974-019-1552-y
- Chiu, M., Lebenbaum, M., Cheng, J., de Oliveira, C., & Kurdyak, P. (2017). The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada. PLOS One, 12(9), e0184268. https://doi.org/https://doi.org/10.1371/journal.pone.0184268
- Chow, W., Doane, M. J., Jack, S., Alphs, L., & Le, H. (2019). Economic burden among patients with major depressive disorder: An analysis of healthcare resource use, work productivity, and direct and indirect costs by depression severity. The American Journal of Managed Care. https://www.ajmc.com/view/economic-burden-mdd
- Cooper, J. A., Arulpragasam, A. R., & Treadway, M. T. (2018). Anhedonia in depression: Biological mechanisms and computational models. Current Opinion in Behavioral Sciences, 22, 128–135. https://doi.org/https://doi.org/10.1016/j.cobeha.2018.01.024
- Correll, C. U., & Schooler, N. R. (2020). Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment. Neuropsychiatric Disease and Treatment, 16, 519–534. https://doi.org/https://doi.org/10.2147/NDT.S225643
- Cox, L. M., & Weiner, H. L. (2018). Microbiota signaling pathways that influence neurologic disease. Neurotherapeutics, 15(1), 135–145. https://doi.org/https://doi.org/10.1007/s13311-017-0598-8
- Dantzer, R., Meagher, M. W., & Cleeland, C. S. (2012). Translational approaches to treatment-induced symptoms in cancer patients. Nature Reviews Clinical Oncology, 9(7), 414–426. https://doi.org/https://doi.org/10.1038/nrclinonc.2012.88
- Dunlop, B. W., LoParo, D., Kinkead, B., Mletzko-Crowe, T., Cole, S. P., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2019). Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. The American Journal of Psychiatry, 176(4), 275–286. https://doi.org/https://doi.org/10.1176/appi.ajp.2018.18091075
- Dunn, E. C., Brown, R. C., Dai, Y., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. W. (2015). Genetic determinants of depression: Recent findings and future directions. Harvard Review of Psychiatry, 23(1), 1–18. https://doi.org/https://doi.org/10.1097/HRP.0000000000000054
- Egede, L. E., Bishu, K. G., Walker, R. J., & Dismuke, C. E. (2016). Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011. Journal of Affective Disorders, 195, 119–126. https://doi.org/https://doi.org/10.1016/j.jad.2016.02.011
- EPHH. (1998). Effective Public Health Practice Project. Quality assessment tool for quantitative studies. http://www.ephpp.ca/PDF/Quality%20Assessment%20Tool_2010_2.pdf
- Ghaisas, S., Maher, J., & Kanthasamy, A. (2016). Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacology & Therapeutics, 158, 52–62. https://doi.org/https://doi.org/10.1016/j.pharmthera.2015.11.012
- Grzesiak, M., Beszłej, J. A., Waszczuk, E., Szechiński, M., Szewczuk-Bogusławska, M., Frydecka, D., Dobosz, T., Jonkisz, A., Lebioda, A., Małodobra, M., & Mulak, A. (2017). Serotonin-related gene variants in patients with irritable bowel syndrome and depressive or anxiety disorders. Gastroenterology Research and Practice, 2017, 4290430–4290439. https://doi.org/https://doi.org/10.1155/2017/4290430
- Hartung, T. J., Brähler, E., Faller, H., Härter, M., Hinz, A., Johansen, C., Keller, M., Koch, U., Schulz, H., Weis, J., & Mehnert, A. (2017). The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types. European Journal of Cancer (Oxford, England: 1990), 72, 46–53. https://doi.org/https://doi.org/10.1016/j.ejca.2016.11.017
- HE. (2016). Helping public health use best evidence in practice since 2005: Quality Assessment Tool – Review articles. Health Evidence. https://www.healthevidence.org/documents/our-appraisal-tools/QA_Tool&Dictionary_10Nov16.pdf
- Hek, K., Demirkan, A., Lahti, J., Terracciano, A., Teumer, A., Cornelis, M. C., Amin, N., Bakshis, E., Baumert, J., Ding, J., Liu, Y., Marciante, K., Meirelles, O., Nalls, M. A., Sun, Y. V., Vogelzangs, N., Yu, L., Bandinelli, S., Benjamin, E. J., … Murabito, J. (2013). A genome-wide association study of depressive symptoms. Biological Psychiatry, 73(7), 667–678. https://doi.org/https://doi.org/10.1016/j.biopsych.2012.09.033
- Helal, S. I., Lee, G., Evans, C., & Grealish, A. (2020). The efficacy of psychological interventions on health-related quality of life for patients with heart failure and depression: A systematic review. Journal of Cardiovascular Nursing. https://doi.org/https://doi.org/10.1097/JCN.0000000000000779
- Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015). Neuroimmune mechanisms of depression. Nature Neuroscience, 18(10), 1386–1393. https://doi.org/https://doi.org/10.1038/nn.4113
- Keller, S., Yang, M., Treadwell, M. J., & Hassell, K. L. (2017). Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: Comparison of PROMIS® to ASCQ-Me. Health and Quality of Life Outcomes, 15(1), 117–117. https://doi.org/https://doi.org/10.1186/s12955-017-0661-5
- Kneipp, S. M., Kairalla, J. A., Stacciarini, J., & Pereira, D. (2009). The Beck Depression Inventory II factor structure among low-income women. Nursing Research, 58(6), 400–409. https://doi.org/https://doi.org/10.1097/NNR.0b013e3181bee5aa
- Lee, S.-A., Jeon, J. Y., No, S.-K., Park, H., Kim, O.-J., Kwon, J.-H., & Jo, K.-D. (2018). Factors contributing to anxiety and depressive symptoms in adults with new-onset epilepsy. Epilepsy & Behavior, 88, 325–331. https://doi.org/https://doi.org/10.1016/j.yebeh.2018.10.005
- Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ (Clinical Research ed.), 365, l1476. https://doi.org/https://doi.org/10.1136/bmj.l1476
- Liang, S., Wu, X., Hu, X., Wang, T., & Jin, F. (2018). Recognizing depression from the microbiota–gut–brain axis. International Journal of Molecular Sciences, 19(6), 1592. https://doi.org/https://doi.org/10.3390/ijms19061592
- Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017). From serotonin to neuroplasticity: Evolvement of theories for major depressive disorder. Frontiers in Cellular Neuroscience, 11, 305–305. https://doi.org/https://doi.org/10.3389/fncel.2017.00305
- Marathe, S. V., D’almeida, P. L., Virmani, G., Bathini, P., & Alberi, L. (2018). Effects of monoamines and antidepressants on astrocyte physiology: Implications for monoamine hypothesis of depression. Journal of Experimental Neuroscience, 12, 1179069518789149. https://doi.org/https://doi.org/10.1177/1179069518789149
- McCabe, B. E., Vermeesch, A. L., Hall, R. F., Peragallo, N. P., & Mitrani, V. B. (2011). Acculturation and the Center for Epidemiological Studies-Depression Scale for Hispanic women. Nursing Research, 60(4), 270–275. https://doi.org/https://doi.org/10.1097/NNR.0b013e318221b8dc
- McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013). Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry, 70(8), 821–829. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2013.143
- Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013). Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits. Depression and Anxiety, 30(4), 297–306. https://doi.org/https://doi.org/10.1002/da.22084
- Mohajeri, M. H., La Fata, G., Steinert, R. E., & Weber, P. (2018). Relationship between the gut microbiome and brain function. Nutrition Reviews, 76(7), 481–496. https://doi.org/https://doi.org/10.1093/nutrit/nuy009
- Nature. (2020). Machine learning. Springer Nature Limited. https://www.nature.com/subjects/machine-learning
- Ng, Q. X., Peters, C., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2018). A meta-analysis of the use of probiotics to alleviate depressive symptoms. Journal of Affective Disorders, 228, 13–19. https://doi.org/https://doi.org/10.1016/j.jad.2017.11.063
- NIH. (2020). Single nucleotide polymorphisms (SNPs). National Institute of Health. https://www.genome.gov/genetics-glossary/Single-Nucleotide-Polymorphisms
- Obrenovich, M. (2018). Leaky gut, leaky brain? Microorganisms, 6(4), 107. https://doi.org/https://doi.org/10.3390/microorganisms6040107
- Okbay, A., Baselmans, B. M. L., De Neve, J.-E., Turley, P., Nivard, M. G., Fontana, M. A., Meddens, S. F. W., Linnér, R. K., Rietveld, C. A., Derringer, J., Gratten, J., Lee, J. J., Liu, J. Z., de Vlaming, R., Ahluwalia, T. S., Buchwald, J., Cavadino, A., Frazier-Wood, A. C., Furlotte, N. A., … Cesarini, D. (2016). Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nature Genetics, 48(6), 624–633. https://doi.org/https://doi.org/10.1038/ng.3552
- Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016). Major depressive disorder. Nature Reviews Disease Primers, 2, 16065. https://doi.org/https://doi.org/10.1038/nrdp.2016.65
- Porgo, T. V., Norris, S. L., Salanti, G., Johnson, L. F., Simpson, J. A., Low, N., Egger, M., & Althaus, C. L. (2019). The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary. Research Synthesis Methods, 10(1), 125–133. https://doi.org/https://doi.org/10.1002/jrsm.1333
- Roy, M., Tapadia, M. G., Joshi, S., & Koch, B. (2014). Molecular and genetic basis of depression. Journal of Genetics, 93(3), 879–892. https://doi.org/https://doi.org/10.1007/s12041-014-0449-x
- Rugulies, R., Sørensen, K., Aldrich, P. T., Folker, A. P., Friborg, M. K., Kjaer, S., Nielsen, M. B. D., Sørensen, J. K., & Madsen, I. E. H. (2020). Onset of workplace sexual harassment and subsequent depressive symptoms and incident depressive disorder in the Danish workforce. Journal of Affective Disorders, 277, 21–29. https://doi.org/https://doi.org/10.1016/j.jad.2020.06.058
- Searight, H. R., & Montone, K. (2017). Profile of mood states. In V. Zeigler-Hill & T. K. Shackelford (Eds.), Encyclopedia of personality and individual differences. Springer.
- Shadrina, M., Bondarenko, E. A., & Slominsky, P. A. (2018). Genetics factors in major depression disease. Frontiers in Psychiatry, 9, 334. https://doi.org/https://doi.org/10.3389/fpsyt.2018.00334
- Sim, J. A., Young Ae, K., Kim, J. H., Lee, J. M., Kim, M. S., Shim, Y. M., Zo, J. I., & Yun, Y. H. (2020). The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: Applications of machine learning. Scientific Reports, 10(1), 10693. https://doi.org/https://doi.org/10.1038/s41598-020-67604-3
- Smarr, K. L., & Keefer, A. L. (2011). Measures of depression and depressive symptoms: Beck Depression Inventory‐II (BDI‐II), Center for Epidemiologic Studies Depression Scale (CES‐D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire‐9 (PHQ‐9). Arthritis Care & Research, 63(S11), S454–S466. https://doi.org/https://doi.org/10.1002/acr.20556
- Smith, L. K., & Wissel, E. F. (2019). Microbes and the mind: How bacteria shape affect, neurological processes, cognition, social relationships, development, and pathology. Perspectives on Psychological Science, 14(3), 397–418. https://doi.org/https://doi.org/10.1177/1745691618809379
- Solis, E., Antypa, N., Conijn, J. M., Kelderman, H., & Van der Does, W. (2017). Psychometric properties of the Leiden Index of Depression Sensitivity (LEIDS). Psychological Assessment, 29(2), 158–171. https://doi.org/https://doi.org/10.1037/pas0000326
- Strawbridge, R., Young, A. H., & Cleare, A. J. (2018). Biomarkers for depression: Recent insights, current challenges and future prospects. Focus (American Psychiatric Publishing), 16(2), 194–209. https://doi.org/https://doi.org/10.1176/appi.focus.16206
- Swardfager, W., Rosenblat, J. D., Benlamri, M., & McIntyre, R. S. (2016). Mapping inflammation onto mood: Inflammatory mediators of anhedonia. Neuroscience and Biobehavioral Reviews, 64, 148–166. https://doi.org/https://doi.org/10.1016/j.neubiorev.2016.02.017
- Thomas, B. H., Ciliska, D., Dobbin, M., & Micucci, S. (2004). A process for systematically reviewing the literature: Providing the research evidence for public health nursing interventions. Worldviews on Evidence-Based Nursing, 1(3), 176–184. https://doi.org/https://doi.org/10.1111/j.1524-475X.2004.04006.x
- Tobias, K. G., Lehrfeld, J., Rosenfeld, B., Pessin, H., & Breitbart, W. (2017). Confirmatory factor analysis of the Beck Depression Inventory–II in patients with advanced cancer: A theory-driven approach. Palliative and Supportive Care, 15(6), 704–709. https://doi.org/https://doi.org/10.1017/S1478951517000724
- Wallace, C. J. K., & Milev, R. (2017). Erratum to: The effects of probiotics on depressive symptoms in humans: A systematic review. Annals of General Psychiatry, 16(1), 10–18. https://doi.org/https://doi.org/10.1186/s12991-017-0141-7
- Wang, J., Wu, X., Lai, W., Long, E., Zhang, X., Li, W., Zhu, Y., Chen, C., Zhong, X., Liu, Z., Wang, D., & Lin, H. (2017). Prevalence of depression and depressive symptoms among outpatients: A systematic review and meta-analysis. BMJ Open, 7(8), e017173. https://doi.org/https://doi.org/10.1136/bmjopen-2017-017173
- Wardenaar, K. J., Riese, H., Giltay, E. J., Eikelenboom, M., van Hemert, A. M., Beekman, A., Penninx, B., & Schoevers, R. (2021). Common and specific determinants of 9-year depression and anxiety course-trajectories: A machine-learning investigation in the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders, 293, 295–304. https://doi.org/https://doi.org/10.1016/j.jad.2021.06.029
- WHO. (2020). Depression. https://www.who.int/news-room/fact-sheets/detail/depression
- Winer, E. S., Jordan, D. G., & Collins, A. C. (2019). Conceptualizing anhedonias and implications for depression treatments. Psychology Research and Behavior Management, 12, 325–335. https://doi.org/https://doi.org/10.2147/PRBM.S159260
- Wise, R. A. (2008). Dopamine and reward: The anhedonia hypothesis 30 years on. Neurotoxicity Research, 14(2–3), 169–183. https://doi.org/https://doi.org/10.1007/BF03033808
- Xia, J., Lu, Z., Feng, S., Yang, J., & Ji, M. (2018). Different effects of immune stimulation on chronic unpredictable mild stress-induced anxiety- and depression-like behaviors depending on timing of stimulation. International Immunopharmacology, 58, 48–56. https://doi.org/https://doi.org/10.1016/j.intimp.2018.03.010
- Xue, R., Zhang, H., Pan, J., Du, Z., Zhou, W., Zhang, Z., Tian, Z., Zhou, R., & Bai, L. (2018). Peripheral dopamine controlled by gut microbes inhibits invariant natural killer T Cell-Mediated Hepatitis. Frontiers in Immunology, 9, 2398. https://doi.org/https://doi.org/10.3389/fimmu.2018.02398
- Yarlagadda, A., Alfson, E., & Clayton, A. H. (2009). The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont), 6(11), 18–22.
- Zamani, M., Alizadeh-Tabari, S., & Zamani, V. (2019). Systematic review with meta-analysis: The prevalence of anxiety and depression in patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 50(2), 132–143. https://doi.org/https://doi.org/10.1111/apt.15325